Avid Bioservices, Inc., a dedicated biologics contract development and manufacturing organization (CDMO), has opened the analytical and process development (AD/PD) suites within the company’s new viral vector development and CGMP manufacturing facility. The launch of the AD/PD labs comes eight months after Avid announced plans to expand its CDMO service offering into the rapidly growing cell and gene therapy market. Build-out of the viral vector facility’s CGMP manufacturing suites is ongoing, w...